Dark green cuboid-shaped crystals of the composition {[P(o-tolyl) 3]Br} 2[Cu 2Br 6](Br 2) are obtained by the reaction of P(o-tolyl) 3 and CuBr 2 with Br 2 in the ionic liquid [NMeBu 3][N(Tf) 2]. The bromocuprate crystallizes triclinic [space group P1; Z = 1; a = 10.667(2) A; b = 10.695(2) A; c = 11.582(2) A; alpha = 74.42(3) degrees ; beta = 75.64(3) degrees ; and gamma = 85.68(3) degrees ]. The title compound is constituted of {[P(o-tolyl) 3]Br} (+) cations and [Cu 2Br 6] (2-) anions and contains molecular dibromine [d Br-Br = 2.341(1) A]. The latter is verified by thermogravimetry and mass spectrometry.
No takes yet. Share an insight, caveat, or question.
Okrut et al. (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: